GLAXOSMITHKLINE FDA Approval ANDA 061859

ANDA 061859

GLAXOSMITHKLINE

FDA Drug Application

Application #061859

Application Sponsors

ANDA 061859GLAXOSMITHKLINE

Marketing Status

Discontinued001
Discontinued002

Application Products

001CAPSULE;ORAL250MG0ANSPORCEPHRADINE
002CAPSULE;ORAL500MG0ANSPORCEPHRADINE

FDA Submissions

ORIG1AP1974-10-01

CDER Filings

GLAXOSMITHKLINE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 61859
            [companyName] => GLAXOSMITHKLINE
            [docInserts] => ["",""]
            [products] => [{"drugName":"ANSPOR","activeIngredients":"CEPHRADINE","strength":"250MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"ANSPOR","activeIngredients":"CEPHRADINE","strength":"500MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ANSPOR","submission":"CEPHRADINE","actionType":"250MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"ANSPOR","submission":"CEPHRADINE","actionType":"500MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.